Medidata Solutions Inc. (NASDAQ:MDSO) President Vries Glen Michael De sold 7,500 shares of the stock in a transaction that occurred on Tuesday, October 11th. The stock was sold at an average price of $54.72, for a total transaction of $410,400.00. Following the sale, the president now owns 942,653 shares in the company, valued at approximately $51,581,972.16. The transaction was disclosed in a document filed with the SEC, which is available at this link.

Vries Glen Michael De also recently made the following trade(s):

  • On Monday, September 12th, Vries Glen Michael De sold 7,500 shares of Medidata Solutions stock. The stock was sold at an average price of $53.70, for a total transaction of $402,750.00.
  • On Tuesday, August 9th, Vries Glen Michael De sold 7,500 shares of Medidata Solutions stock. The shares were sold at an average price of $54.39, for a total transaction of $407,925.00.

Shares of Medidata Solutions Inc. (NASDAQ:MDSO) opened at 52.32 on Friday. The company’s 50-day moving average is $55.00 and its 200 day moving average is $48.41. The stock has a market capitalization of $2.91 billion, a P/E ratio of 134.50 and a beta of 1.29. Medidata Solutions Inc. has a 12 month low of $30.22 and a 12 month high of $57.21.

Medidata Solutions (NASDAQ:MDSO) last issued its earnings results on Wednesday, July 20th. The company reported $0.24 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.23 by $0.01. The firm earned $114.60 million during the quarter, compared to analyst estimates of $112.39 million. Medidata Solutions had a net margin of 5.29% and a return on equity of 10.32%. The business’s revenue was up 16.8% on a year-over-year basis. During the same period in the previous year, the firm earned $0.22 earnings per share. Equities research analysts predict that Medidata Solutions Inc. will post $1.01 earnings per share for the current year.

Insider Buying and Selling by Quarter for Medidata Solutions (NASDAQ:MDSO)

Several equities analysts recently commented on the stock. Wells Fargo & Co. downgraded shares of Medidata Solutions from an “outperform” rating to a “market perform” rating in a research note on Thursday, July 21st. Deutsche Bank AG increased their price objective on shares of Medidata Solutions from $56.00 to $58.00 and gave the company a “buy” rating in a research note on Tuesday, September 13th. KeyCorp reissued a “buy” rating on shares of Medidata Solutions in a research note on Thursday, July 7th. Zacks Investment Research downgraded shares of Medidata Solutions from a “buy” rating to a “hold” rating in a research note on Wednesday, July 13th. Finally, Needham & Company LLC assumed coverage on shares of Medidata Solutions in a research note on Monday, July 11th. They issued a “buy” rating and a $55.00 price objective for the company. One research analyst has rated the stock with a sell rating, three have issued a hold rating and nine have issued a buy rating to the company’s stock. The stock has a consensus rating of “Buy” and a consensus target price of $54.09.

Several hedge funds have recently modified their holdings of the stock. LS Investment Advisors LLC raised its stake in shares of Medidata Solutions by 9.2% in the second quarter. LS Investment Advisors LLC now owns 2,411 shares of the company’s stock worth $113,000 after buying an additional 203 shares in the last quarter. BlackRock Inc. raised its stake in shares of Medidata Solutions by 127.8% in the first quarter. BlackRock Inc. now owns 3,690 shares of the company’s stock worth $143,000 after buying an additional 2,070 shares in the last quarter. Tower Research Capital LLC TRC raised its stake in shares of Medidata Solutions by 5.3% in the second quarter. Tower Research Capital LLC TRC now owns 3,498 shares of the company’s stock worth $164,000 after buying an additional 177 shares in the last quarter. Parkwood LLC bought a new stake in shares of Medidata Solutions during the second quarter worth about $200,000. Finally, Shelton Capital Management bought a new stake in shares of Medidata Solutions during the second quarter worth about $218,000.

Medidata Solutions Company Profile

Medidata Solutions Inc (Medidata) is a provider of cloud-based solutions for life sciences. The Company provides cloud-based solutions for clinical research in life sciences, offering platform technology that focuses on the clinical development. The Medidata Clinical Cloud provides a platform of technology and data analytics solutions designed to manage activities across clinical development.

5 Day Chart for NASDAQ:MDSO

Receive News & Stock Ratings for Medidata Solutions Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medidata Solutions Inc. and related stocks with our FREE daily email newsletter.